Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience

被引：0
|
作者：
Oscar Epis
Cinzia Casu
Laura Belloli
Emanuela Schito
Davide Filippini
Marina Muscarà
Eleonora Bruschi
机构：
[1] Niguarda Ca’ Granda Hospital,Rheumatology Unit
来源：
Rheumatology International | 2015年 / 35卷
关键词：
Rheumatoid Arthritis; Rheumatoid Arthritis Patient; Clinical Remission; Tocilizumab; Disease Remission;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1569 / 1570
页数：1
相关论文
共 50 条
  • [21] Body Mass Index and Clinical Response to Tocilizumab in Patients With Rheumatoid Arthritis
    Huang, Hua
    Cen, Han
    Zhou, Li
    Wang, Ting-hui
    Qin, Wen
    Xie, Bin-hua
    Xiao, Dong-Mei
    Wu, Xiu-Di
    Wu, Hua-Xiang
    ARCHIVES OF RHEUMATOLOGY, 2019, 34 (04) : 406 - 413
  • [22] The clinical value of hematological markers in rheumatoid arthritis patients treated with tocilizumab
    Zhou, Li
    Xiao, Dong-Mei
    Qin, Wen
    Xie, Bin-Hua
    Wang, Ting-Hui
    Huang, Hua
    Zhao, Bao-Jing
    Han, Xi
    Sun, Qing-Qing
    Wu, Xiu-Di
    Cen, Han
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2019, 33 (05)
  • [23] Remission of Rheumatoid Arthritis and Primary Biliary Cholangitis After Treatment With Tocilizumab
    Azevedo, Soraia
    Sousa-Neves, Joana
    Rodrigues, Joana Ramos
    Peixoto, Daniela
    Tavares-Costa, Jose
    Teixeira, Filipa
    REUMATOLOGIA CLINICA, 2021, 17 (06): : 364 - 365
  • [24] Disease activity score 28 may overestimate the remission induction of rheumatoid arthritis patients treated with tocilizumab: comparison with the remission by the clinical disease activity index
    Kawashiri, Shin-ya
    Kawakami, Atsushi
    Iwamoto, Naoki
    Fujikawa, Keita
    Aramaki, Toshiyuki
    Tamai, Mami
    Yamasaki, Satoshi
    Nakamura, Hideki
    Ueki, Yukitaka
    Migita, Kiyoshi
    Mizokami, Akinari
    Origuchi, Tomoki
    Aoyagi, Kiyoshi
    Eguchi, Katsumi
    MODERN RHEUMATOLOGY, 2011, 21 (04) : 365 - 369
  • [25] The addition of iguratimod can reduce methotrexate dose in rheumatoid arthritis with clinical remission
    Yoshikawa, Ayaka
    Kotani, Takuya
    Matsuda, Shogo
    Hata, Kenichiro
    Matsumura, Yoko
    Takeuchi, Tohru
    MODERN RHEUMATOLOGY, 2022, 32 (01) : 68 - 73
  • [26] Remission in rheumatoid arthritis patients treated with etanercept monotherapy: clinical practice and clinical trial experience
    Cannon, G. W.
    Wang, B. C.
    Park, G. S.
    Koenig, A.
    Collier, D. H.
    Keystone, E. C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (06) : 919 - 925
  • [27] Real World Dose Modification Patterns of Subcutaneous Tocilizumab Among Patients with Rheumatoid Arthritis
    Punekar, Rajeshwari
    Choi, Jeannie
    Boklage, Susan
    Iglesias-Rodriguez, Melitza
    Nola, Kamala
    AMERICAN HEALTH AND DRUG BENEFITS, 2019, 12 (08): : 400 - 409
  • [28] Clinical safety of tocilizumab in rheumatoid arthritis
    Bannwarth, Bernard
    Richez, Christophe
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (01) : 123 - 131
  • [29] Utility of Dose Frequency Adjustment in Tocilizumab Administration for Rheumatoid Arthritis
    Saito, Shuntaro
    Kaneko, Yuko
    Izumi, Keisuke
    Takeuchi, Tsutomu
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (05) : 553 - 557
  • [30] Clinical efficacy and safety of tocilizumab in the treatment of seropositive rheumatoid arthritis patients in India
    Kumar, Abhishek
    Bhakuni, Darshan
    Shanmuganandan, K.
    Hegde, Arun
    Vasdev, Vivek
    Arjun, M. N.
    Kishore, Kunal
    INDIAN JOURNAL OF RHEUMATOLOGY, 2020, 15 (04) : 286 - 291
12345